Chemed Change in Accounts Receivable 2010-2025 | CHE

Chemed change in accounts receivable for the twelve months ending June 30, 2025 was $-0.085B, a 27.32% increase year-over-year.

  • Chemed annual change in accounts receivable for 2024 was $0.011B, a 125.74% decline from 2023.
  • Chemed annual change in accounts receivable for 2023 was $-0.041B, a 1618.64% increase from 2022.
  • Chemed annual change in accounts receivable for 2022 was $-0.002B, a 71.37% decline from 2021.

Chemed Change in Accounts Receivable 2010-2025 | CHE

  • Chemed annual change in accounts receivable for 2024 was $0.011B, a 125.74% decline from 2023.
  • Chemed annual change in accounts receivable for 2023 was $-0.041B, a 1618.64% increase from 2022.
  • Chemed annual change in accounts receivable for 2022 was $-0.002B, a 71.37% decline from 2021.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$20.2B
Encompass Health (EHC)$12.4B
DaVita (DVA)$10B
Elanco Animal Health (ELAN)$8.9B
RadNet (RDNT)$5.4B
Option Care Health (OPCH)$4.7B
Amedisys (AMED)$3.3B
Addus HomeCare (ADUS)$2.2B
LifeStance Health (LFST)$2.2B
Astrana Health (ASTH)$1.7B
Aveanna Healthcare Holdings (AVAH)$1.6B
U.S Physical Therapy (USPH)$1.3B
Atai Life Sciences (ATAI)$980M
Pennant (PNTG)$870M
Daxor (DXR)$53M
MEDIROM Healthcare Technologies (MRM)$50M
Psychemedics (PMD)$0M